In an embryonal carcinoma model with heterogeneous CD30 antigen expression, Hong et al. found that CD30-specific CAR T cells used this mechanism to eliminate CD30-negative or dim-expressing tumor cells. Here, TNFRSF8 is linked to embryonal carcinoma.